Bladder Procedures
Intravesical Therapy (BCG / Chemotherapy into the Bladder)
Medication placed directly into the bladder through a catheter to reduce recurrence of certain bladder cancers after TURBT.
01What is it?
Intravesical therapy delivers BCG (immunotherapy) or chemotherapy solution into the bladder, where it acts on the lining with limited effect on the rest of the body.
02When is treatment considered?
Recommended after TURBT for intermediate- and high-risk non-muscle-invasive bladder cancer, and sometimes immediately after surgery for lower-risk tumours.
03Available treatment options
Depending on risk category, alternatives include surveillance alone, or more intensive approaches when BCG is unsuitable or the cancer persists.
04What does the procedure involve?
A catheter instils the medication, which is held in the bladder for a set time before passing urine. BCG is usually given weekly for 6 weeks, often followed by maintenance courses.
05Expected recovery
Outpatient treatment; normal activity the same day.
06Common risks
Bladder irritation (frequency, burning, blood in urine), flu-like symptoms with BCG, and rarely BCG infection requiring specific treatment.
07When to seek medical attention
High fever after BCG, or severe persistent bladder symptoms, should be reported before the next instillation.
08Frequently asked questions
This website provides general educational information and is not a substitute for an individual medical consultation. Diagnosis and treatment should be based on assessment by a qualified healthcare professional.